Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Asset Writedowns and Impairment (2024 - 2025)

Historic Asset Writedowns and Impairment for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $24000.0.

  • Beta Bionics' Asset Writedowns and Impairment changed N/A to $24000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $50000.0, marking a year-over-year change of. This contributed to the annual value of $70000.0 for FY2024, which is 5217.39% up from last year.
  • Latest data reveals that Beta Bionics reported Asset Writedowns and Impairment of $24000.0 as of Q3 2025.
  • In the past 5 years, Beta Bionics' Asset Writedowns and Impairment registered a high of $27000.0 during Q2 2024, and its lowest value of $17000.0 during Q1 2024.